Articles

More 3D mammography

FUJIFILM Medical Systems U.S.A., Inc. announces nine additional healthcare systems which have chosen their ASPIRE Cristalle mammography systems with 3D imaging
Written byDDNews Staff
| 2 min read

STAMFORD, Conn.—Today, FUJIFILM Medical Systems U.S.A., Inc., a provider of diagnostic imaging products including digital radiography and women's health solutions, announced nine of the initial healthcare systems across the United States which have selected Fujifilm's ASPIRE Cristalle mammography system with 3D imaging or Digital Breast Tomosynthesis (DBT) option in order to improve their diagnostic imaging capabilities and patient outcomes.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue